Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sight Sciences, Inc.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participated in, received treatment, and completed Protocol #06213
You may not be if
Systemic disease that, in the opinion of the Investigator, would put the subject's health at risk and/or prevent completion of required study visits
Ocular pathology which, in the Investigator's judgment, would either place the subject at increased risk of complications, contraindicate washout, place the subject at risk of significant vision loss during the study period (e.g., wet age macular degeneration (AMD), corneal edema, Fuch's dystrophy, active intraocular infection or inflammation within 30 days prior to Screening Visit, etc.), or interfere with compliance to elements of the study protocol (e.g., returning to Investigator's office for follow-up visits)
Clareo Health | A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
